cilostazol has been researched along with Colonic Neoplasms in 2 studies
Colonic Neoplasms: Tumors or cancer of the COLON.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We previously reported the anti-inflammatory effects of cilostazol, a selective inhibitor of phosphodiesterase 3, and two antioxidants, enzymatically modified isoquercitrin and α-lipoic acid in a dextran sodium sulphate-induced colitis mouse model." | 7.85 | Cilostazol and enzymatically modified isoquercitrin attenuate experimental colitis and colon cancer in mice by inhibiting cell proliferation and inflammation. ( Hayashi, SM; Hippo, Y; Kangawa, Y; Kihara, T; Maruyama, K; Nakamura, M; Ochiai, M; Okamoto, M; Shibutani, M; Yoshida, T, 2017) |
| "We previously reported the anti-inflammatory effects of cilostazol, a selective inhibitor of phosphodiesterase 3, and two antioxidants, enzymatically modified isoquercitrin and α-lipoic acid in a dextran sodium sulphate-induced colitis mouse model." | 3.85 | Cilostazol and enzymatically modified isoquercitrin attenuate experimental colitis and colon cancer in mice by inhibiting cell proliferation and inflammation. ( Hayashi, SM; Hippo, Y; Kangawa, Y; Kihara, T; Maruyama, K; Nakamura, M; Ochiai, M; Okamoto, M; Shibutani, M; Yoshida, T, 2017) |
| "Treatment with cilostazol (50 microM) suppressed 92." | 1.30 | Phosphodiesterase type III inhibitor, cilostazol, inhibits colon cancer cell motility. ( Akedo, H; Fukui, F; Hiratsuka, M; Imaoka, S; Ishikawa, O; Kabuto, T; Kameyama, M; Mammoto, T; Mukai, M; Murata, K; Ohigashi, H; Sasaki, Y, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kangawa, Y | 1 |
| Yoshida, T | 1 |
| Maruyama, K | 1 |
| Okamoto, M | 1 |
| Kihara, T | 1 |
| Nakamura, M | 1 |
| Ochiai, M | 1 |
| Hippo, Y | 1 |
| Hayashi, SM | 1 |
| Shibutani, M | 1 |
| Murata, K | 1 |
| Kameyama, M | 1 |
| Fukui, F | 1 |
| Ohigashi, H | 1 |
| Hiratsuka, M | 1 |
| Sasaki, Y | 1 |
| Kabuto, T | 1 |
| Mukai, M | 1 |
| Mammoto, T | 1 |
| Akedo, H | 1 |
| Ishikawa, O | 1 |
| Imaoka, S | 1 |
2 other studies available for cilostazol and Colonic Neoplasms
| Article | Year |
|---|---|
Cilostazol and enzymatically modified isoquercitrin attenuate experimental colitis and colon cancer in mice by inhibiting cell proliferation and inflammation.
Topics: Animals; Azoxymethane; Carcinogens; Cell Proliferation; Cilostazol; Colitis; Colonic Neoplasms; Enzy | 2017 |
Phosphodiesterase type III inhibitor, cilostazol, inhibits colon cancer cell motility.
Topics: Animals; Cattle; Cell Movement; Cilostazol; Colonic Neoplasms; Humans; Phosphodiesterase Inhibitors; | 1999 |